Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
About a third of participants (28 people) receiving lixisenatide opted for a lower dose during the study due to side effects
It states tirzepatide produced approximately 20 to 25 percent greater weight loss than semaglutide at maximum amounts in clinical trials
In the general obesity population, cost-effectiveness is highly sensitive to drug price, treatment duration, and reimbursement context, and published models have reached variable conclusions (201203)
It communicates with several organs: Pancreas: Signals insulin release and suppresses glucagon, lowering blood sugar
US$ 22.51
US$ 26.64
US$ 26.41
